Cosmetic Surgery and Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Cosmetic Surgery and Services Market is segmented by Treatment Type (Surgical and Non-surgical) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Cosmetic Surgery and Procedures Market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The cosmetic surgery and services market is projected to register a CAGR of 5.5% during the forecast period (2021-2026).

According to a research article by Dana E Bregman et al., published in the Aesthetic Surgery Journal July 2020, in the United States, the total surgeons' fees derived from both surgical and minimally invasive procedures in 2018 was approximately 5 billion dollars. The current pandemic had resulted in an approximately 20% decrease in collected fees, which is expected to show a negative impact on the market studied in 2020. As the COVID-19 pandemic has grown in magnitude, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures has become questionable. Additionally, a slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, imposing a practical restriction.

The key factors propelling the growth of this market are technological advancements in devices, growing demand for minimally invasive and non-invasive procedures, and growing awareness regarding cosmetic surgery. According to the annual plastic surgery procedural statistics, in 2019, 1.8 million cosmetic surgical procedures and 16.3 million cosmetic minimally invasive procedures were performed in the United States, with a 2% increase in the number of procedures over 2018. Thus, the growing popularity of aesthetic treatment for facial enhancement is the key driver of this market.

The demand for cosmetic surgeries and minimally invasive procedures, such as botulinum toxin and facial filler injections, has increased dramatically over the past decade. It has been observed since the past few years that US citizens are spending more money on cosmetic surgeries. Market players are frequently launching technologically advanced products, which is likely to drive the segment growth during the forecast period. For instance, in 2019, Merz, one of the global player in medical aesthetics, launched the Belotero Revive, a dermal filler product containing a unique combination of hyaluronic acid (HA) and glycerol, designed to improve hydration, elasticity and firmness of the skin and to address the appearance of fine lines.Owing to these aforementioned factors, along with technological advancements in devices and growing awareness regarding cosmetic surgery, the cosmetic surgery and services market is expected to grow rapidly over the forecast period.

Scope of the Report

Cosmetic plastic surgery includes surgical and non-surgical procedures that enhance and reshape structures of the body to improve appearance and confidence. Since it is elective, cosmetic surgery is usually not covered by health insurance. 

The Cosmetic Surgery and Services Market is segmented by Treatment Type (Surgical and Non-surgical) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Treatment Type
By Surgical
Breast Augmentation
Tummy Tuck
Eyelid Surgery
Breast Lift
By Non-surgical
Botulinum toxin
Dermal Fillers
Laser Hair Removal
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Botulinum Toxin Segment is Expected to Witness the Fastest Growth in the Market

Botulinum toxin is a highly poisonous, naturally occurring substance, but has wide applications. The most common use of this toxin is in the treatment of painful muscle spasms and cosmetic treatment. Botox and Dysport are the commercial names of the botulinum toxin. In 1950, the researchers found that the minute use of this toxin helps in controlling muscle movement. Gradually, they understood that this substance is also beneficial in cosmetic treatments.

According to the American Society of Plastic Surgeons in 2020, there were 13,281,235 cosmetic minimally invasive procedures that were performed in the United States, out of which 4,401,536 were botulinum toxin procedure, and it was the number one non-surgical procedure found in 2020. 

There is also increased competition in the US botulinum toxin market that is set to increase with the launch of Jeuveau. Evolus Inc. in 2019, received the US FDA approval for its lead product, Jeuveau, for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults that was the first new botulinum toxin approved by the FDA since Merz Pharma’s XEOMIN in 2010. Botulinum toxin injection for treatment of facial wrinkles is considered the most frequently performed cosmetic procedure in the United States, and it is the number one aesthetic procedure since 1999. Hence, the use of botulinum toxins in aesthetic medicine has increased, remarkably. Botox injections are used for the treatment of frown lines, crow's feet, and horizontal forehead lines, which are the cosmetic indications approved by the US Food and Drug Administration. It offers predictable results with few adverse effects and is associated with high patient satisfaction with the rising applications of the substance, the segment is expected to experience fast growth across various regions of the world.

Cosmetic Surgery and Procedures Market Key Trends

North America is Expected to Dominate the Market Over the Forecast Period

North America dominates the cosmetic surgery and services market, owing to the rising population pool focusing on external aesthetics and the improvements that are being done in cosmetic procedures. According to the American Society of Plastic Surgeons (ASPS), in 2020, 15.5 million cosmetic procedures were performed in the United States, out of which, 13.2 million were minimally invasive.

As per the International Society of Aesthetic Plastic Surgery, there were 437,880 injectable non-surgical procedures done in Mexico in 2018, which has been increased from 346,206 in 2017. Hyaluronic acid procedures were the second-most common injectable procedure, accounting for a total of 142,217 procedures in 2018.

Currently, people in this region are spending more money on cosmetics and are eager to adopt novel cosmetic treatments this factor is giving rise to a number of market development strategies. For instance, in November 2018, the US FDA approved the hyaluronic acid dermal filler, Restylane Lyft (Galderma), for cheek augmentation and the correction of age-related mid-face contour deficiencies via a small blunt tip cannula in patients over the age of 21. Moreover, in future new product approvals and launches are expected to hit the market, therefore the studied market in this region is expected to witness rapid growth.

Cosmetic Surgery and Procedures Market Growth by Region

Competitive Landscape

The cosmetic surgery and services market is consolidated. Certain key players having the major market share include Abbvie, Bausch Health Companies Inc., Merz Pharma GmbH & Co. KGaA, Galderma SA, and Johnson & Johnson. With the help of product innovation, few small-sized companies are also penetrating the market and are holding a substantial share.

Recent Development

In May 2021, GC Aesthetics, Inc, announced the launch of its next generation of breast implants, PERLE. PERL is a highly innovative line of smooth breast implants that features a proprietary surface technology , GCA's industry-leading gel technology, and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record.

In February 2021, Galderma announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Devices

      2. 4.2.2 Growing Demand for Minimally Invasive and Non-invasive Procedures

      3. 4.2.3 Growing Awareness Regarding Cosmetic Surgery

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Policies

      2. 4.3.2 Side Effects Associated with Cosmetic Treatments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Treatment Type

      1. 5.1.1 By Surgical

        1. Breast Augmentation

        2. Liposuction

        3. Tummy Tuck

        4. Eyelid Surgery

        5. Breast Lift

      2. 5.1.2 By Non-surgical

        1. Botulinum toxin

        2. Dermal Fillers

        3. Laser Hair Removal

        4. Photo-rejuvenation

        5. Microdermabrasion

    2. 5.2 Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.2.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Cynosure Technologies

      4. 6.1.4 Galderma SA

      5. 6.1.5 Laboratories Vivacy SAS

      6. 6.1.6 Merz Pharma GmbH & Co. KGaA

      7. 6.1.7 Sinclair Pharma PLC

      8. 6.1.8 Syneron

      9. 6.1.9 Teoxane Laboratories

      10. 6.1.10 Vital Esthetique

      11. 6.1.11 Johnson and Johnson

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Cosmetic Surgery and Services Market market is studied from 2018 - 2026.

The Global Cosmetic Surgery and Services Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Bausch Health Companies Inc., Galderma  SA, Merz Pharma, Johnson and Johnson, AbbVie Inc. are the major companies operating in Global Cosmetic Surgery and Services Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!